Hydroxychloroquine Synergizes With The PI3K Inhibitor BKM120 to Exhibit Antitumor Efficacy Independent of Autophagy

Xin Peng(The University of Texas MD Anderson Cancer Center), Kong De(Harbin University of Science and Technology)

Research Square

July 13, 2021

10.21203/rs.3.rs-691658/v1

Cited by 0

Related Papers

Distribution patterns of small-molecule ligands in the protein universe and implications for origin of life and drug discovery

|Genome biology|2007|59

Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

|Journal of Experimental & Clinical Cancer Research|2021|56

The mitochondrial antioxidant SS-31 attenuated lipopolysaccharide-induced apoptosis and pyroptosis of nucleus pulposus cells via scavenging mitochondrial ROS and maintaining the stability of mitochondrial dynamics

|Free Radical Research|2021|40

Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer

|Molecular Cancer|2025|3